Session 798: Growth factors & signalling

Date: 1 February 2004, Time: 14:00 - 16:00
Location: Room 4

Oral Presentations

Time	Number	Title / Authors / Affiliations
14:00	79	Molecular and pharmacological characterization of membrane-associated and soluble forms of Hedgehog interacting protein K Loulier, J Coulombe PhD, E Traiffort PhD, M Ruat PhD Laboratoire de Neurobiologie Cellulaire et Moléculaire, CNRS UPR 9040, Gif-sur-Yvette, France
14:15	80	Paracrine growth factor role for Interleukin-18 in AIDS associated human B-cell lines. PhD Sharma, SL Lorey MS^a University of West Florida, Pensacola, FL, USA,(b)Vanderbilt University, Nashville, TN, USA
14:30	81	The IGF-system and the prediction of event risk in children with acute lymphoblastic leukemia. P Vorwerk MD^a, K Mohnike MD PhD^a, H Wex PhD^a, FR Röhl PhD^b, M Zimmermann PhD^c, WF Blum MD PhD^d, U Mittler MD PhD^a (a) Dept. Pediatric Oncology, University Otto von Guericke, Magdeburg, Germany, (b) Institute of Biometrics and Medical Informatics, University Otto von Guericke, Magdeburg, Germany, (c) Dept. Pediatric Oncology, Hannover Medical School, Germany, (d) Lilly Germany GmbH, Bad Homburg, Germany
14:45	82	Prognostic value of tissue vascular endothelial growth factor (VEGF) in breast cancer compared with other common prognostic indicators A Nicolini MD^a, D Campani MD^b, P Ferrari MD^a, M Menicagli PhD^b, L Anselmi MD^a, M Conte MD^c, C Spinelli MD^c ^aDepartment of Internal Medicine, ^bDepartment of Oncology, ^cDepartment of Surgery; University of Pisa, Pisa, Italy
15:00	83	A significant expression of IGFBP2 in infiltrating breast cancer compared to carcinoma in situ and benign lesions LT Busund MD PhD, E Richardsen MD, R Busund MD PhD, T Ukkonen, T Bjoernsen, C Busch MD PhD, H Stalsberg MD PhD Department of Pathology, University Hospital of Northern Norway N-9038 Breivika, Tromsø, Norway
15:15	84	Urinary levels of urokinase-type plasminogen activator receptor are associated with the clinical outcome of pT1 bladder cancers. G Milanese MD^a, G Muzzonigro MD^a, C Vivani PhD^a,b, F Fazioli PhD^b, CFM Sier MD^c, N Sidenius MD^c, F Blasi MD^c ^aDepartment of Urology, Polytechnic University of the Marche Region, Ancona, Italy, ^bInstitute of Clinical Medicine, Polytechnic University of the Marche Region, Ancona, Italy, ^cDepartment of Molecular Pathology and Medicine San Raffaele Scientific Institute and Hospital, Milan, Italy

Poster Presentations

Number	Title / Authors / Affiliations
85	Bcr-Abl regulates Mcl-1 expression in patients with CML PK Epling-Burnette^a,b, F Baia, R Nimanapallia, M Huanga, KN Bhalla^a, R Jovea, TP Loughran^c ^aH. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL, United States, ^bJames A. Haley Veterans’ Administration Hospital, Tampa, FL, United States, ^cPenn State College of Medicine, Penn State Cancer Institute, Hershey, PA, United States
86	(-)-Menthol induced modulation of cell cycle in gastric cancer cells JP Lin MS^a, CS Yu PhD^b, JG Chung PhD^c ^aSchool of Chinese Medicine, ^bCenter of General Education, ^cDepartment of Microbiology; China Medical University, Taichung 400, Taiwan

Number

Title / Authors / Affiliations

Bcr-Abl regulates Mcl-1 expression in patients with CML

PK Epling-Burnette^a,b, F Baia, R Nimanapallia, M Huanga, KN Bhalla^a, R Jovea, TP Loughran^c

^aH. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL, United States, ^bJames A. Haley Veterans’ Administration Hospital, Tampa, FL, United States, ^cPenn State College of Medicine, Penn State Cancer Institute, Hershey, PA, United States

(-)-Menthol induced modulation of cell cycle in gastric cancer cells

JP Lin MS^a, CS Yu PhD^b, JG Chung PhD^c

^aSchool of Chinese Medicine, ^bCenter of General Education, ^cDepartment of Microbiology; China Medical University, Taichung 400, Taiwan